Formic Acid

Formic Acid

SCHEMBL4664322

Cc1ccc(S(=O)(=O)Nc2ccc(Nc3cc(-c4ccc5c(c4)ncn5CCCN(C)C)ncn3)cc2)c(F)c1.O=CO

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 4/20 0.37
ALDH1A1 P00352 2/20 0.36
TGFBR1 P36897 1/20 0.35
BPTF Q12830 5/20 0.35
RORC P51449 1/20 0.34
MAPK1 P28482 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
GLA P06280 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
ABL1 P00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4666063 0.92 NR1I2 (0.46) NR1I2ALDH1A1TGFBR1BPTFMAPK1
Formic Acid SCHEMBL4663967 0.88 NR1I2 (0.40) NR1I2ALDH1A1TGFBR1BPTFMAPK1
SCHEMBL4664328 0.86 MAPK1 (0.36) NR1I2ALDH1A1TGFBR1BPTFMAPK1
Formic Acid SCHEMBL4666201 0.85 BPTF (0.46) BPTF
Formic Acid SCHEMBL4665678 0.83 HTT (0.41) NR1I2ALDH1A1ABL1BCRKIT
Formic Acid SCHEMBL4667433 0.83 JAK1 (0.38) ALDH1A1BPTFRORCMAPK1MEN1
Formic Acid SCHEMBL4666142 0.82 HTR6 (0.40) BPTFRORCABL1BCR
Formic Acid SCHEMBL4665663 0.81 HTR6 (0.45) BPTFRORCABL1BCR
Formic Acid SCHEMBL4663848 0.80 RORC (0.35) ALDH1A1BPTFRORCMAPK1MEN1
Formic Acid SCHEMBL4663890 0.80 PRF1 (0.45) ALDH1A1RORCMAPK1MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors ALTANA PHARMA AG (DE) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors MAP3K19, MAP3K6, MAP3K20 NR1I2 1040/4885ALDH1A1 2988/4885TGFBR1 1515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.